Many patients are not satisfied with electroconvulsive therapy

June 19, 2003

Around 11,000 people receive electroconvulsive therapy in England each year, yet controversy exists as to whether treatment is beneficial and whether patients are satisfied with it.

A study in this week's BMJ finds that at least one third of patients report persistent memory loss after electroconvulsive therapy. This conflicts with the current statement from the Royal College of Psychiatrists that over 80% of patients are satisfied with treatment and that memory loss is not clinically important.

Researchers reviewed 35 studies to ascertain patients' views on electroconvulsive therapy. Twenty-six were carried out by doctors in psychiatric units (clinician led studies) and nine were undertaken by patients or with in collaboration with them (patient led studies).

The level of positive responses varied widely between studies. Patient led studies reported lower rates of perceived benefit than clinician led studies.

The rate of reported persistent memory loss varied between 29% and 55% but, unlike levels of perceived benefit, the rate did not seem to depend on whether studies were clinical or patient based, with relatively high levels being reported by both types of study.

Given these findings, it is not surprising that disputes can arise and that organisations should emerge that provide support for those who feel their treatment has not been beneficial, say the authors.

They conclude that the current statement from the Royal College of Psychiatrists is unfounded.
-end-


BMJ

Related Memory Loss Articles from Brightsurf:

Memory loss reversed or abated in those with cognitive decline
Affirmativ Health sought to determine whether a comprehensive and personalized program, designed to mitigate risk factors of Alzheimer's disease could improve cognitive and metabolic function in individuals experiencing cognitive decline.

Resolving inflammation: Could it prevent memory loss in Down syndrome and Alzheimer's?
Resolvins are lipids that 'resolve' the inflammation that normally follows injury or disease, returning the body back to normal.

Predicting Alzheimer's disease-like memory loss before it strikes
Researchers at Gladstone Institutes are approaching Alzheimer's from a different angle.

Research reveals no link between statins and memory loss
Over 6 years, researchers evaluated the cognitive effects of statins in elderly consumers, revealing no negative impact and potential protective effects in those at risk of dementia.

New drug may protect against memory loss in Alzheimer's disease
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer's disease.

Sugar entering the brain during septic shock causes memory loss
The loss of memory and cognitive function known to afflict survivors of septic shock is the result of a sugar that is released into the blood stream and enters the brain during the life-threatening condition.

Brain stimulation reverses age-related memory loss
Stimulating a precise location of the brain's memory center with electromagnetic pulses improves the memory of older adults with age-related memory loss to the level of young adults, reports a new study.

New molecules reverse memory loss linked to depression, aging
New therapeutic molecules developed at Toronto's Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

Signs of memory problems could be symptoms of hearing loss instead
Older adults concerned about displaying early symptoms of Alzheimer's disease should also consider a hearing check-up, suggest recent findings.

How to reverse memory loss in old mice
A Columbia study in mice has revealed new details of how a naturally occurring bone hormone reverses memory loss in the aging brain.

Read More: Memory Loss News and Memory Loss Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.